Literature DB >> 21874528

Differential pulmonary transcriptomic profiles in murine lungs infected with low and highly virulent influenza H3N2 viruses reveal dysregulation of TREM1 signaling, cytokines, and chemokines.

Fransiskus X Ivan1, Jagath C Rajapakse, Roy E Welsch, Steve G Rozen, T Narasaraju, Gordon M Xiong, Bevin P Engelward, Vincent T Chow.   

Abstract

Investigating the relationships between critical influenza viral mutations contributing to increased virulence and host expression factors will shed light on the process of severe pathogenesis from the systems biology perspective. We previously generated a mouse-adapted, highly virulent influenza (HVI) virus through serial lung-to-lung passaging of a human influenza H3N2 virus strain that causes low virulent influenza (LVI) in murine lungs. This HVI virus is characterized by enhanced replication kinetics, severe lung injury, and systemic spread to major organs. Our gene microarray investigations compared the host transcriptomic responses of murine lungs to LVI virus and its HVI descendant at 12, 48, and 96 h following infection. More intense expression of genes associated with cytokine activity, type 1 interferon response, and apoptosis was evident in HVI at all time-points. We highlighted dysregulation of the TREM1 signaling pathway (an amplifier of cytokine production) that is likely to be upregulated in infiltrating neutrophils in HVI-infected lungs. The cytokine gene expression changes were corroborated by elevated levels of multiple cytokine and chemokine proteins in the bronchoalveolar lavage fluid of infected mice, especially at 12 h post-infection. Concomitantly, the downregulation of genes that mediate proliferative, developmental, and metabolic processes likely contributed to the lethality of HVI as well as lack of lung repair. Overall, our comparative transcriptomic study provided insights into key host factors that influence the dynamics, pathogenesis, and outcome of severe influenza.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21874528     DOI: 10.1007/s10142-011-0247-y

Source DB:  PubMed          Journal:  Funct Integr Genomics        ISSN: 1438-793X            Impact factor:   3.410


  48 in total

1.  Preparing for the next pandemic.

Authors:  Michael T Osterholm
Journal:  N Engl J Med       Date:  2005-05-05       Impact factor: 91.245

2.  Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus.

Authors:  Darwyn Kobasa; Steven M Jones; Kyoko Shinya; John C Kash; John Copps; Hideki Ebihara; Yasuko Hatta; Jin Hyun Kim; Peter Halfmann; Masato Hatta; Friederike Feldmann; Judie B Alimonti; Lisa Fernando; Yan Li; Michael G Katze; Heinz Feldmann; Yoshihiro Kawaoka
Journal:  Nature       Date:  2007-01-18       Impact factor: 49.962

3.  Comparative transcriptional profiling of the lung reveals shared and distinct features of Streptococcus pneumoniae and influenza A virus infection.

Authors:  Simone Rosseau; Andreas Hocke; Hans Mollenkopf; Bernd Schmeck; Norbert Suttorp; Stefan H E Kaufmann; Jens Zerrahn
Journal:  Immunology       Date:  2006-12-08       Impact factor: 7.397

Review 4.  Influenza: lessons from past pandemics, warnings from current incidents.

Authors:  Taisuke Horimoto; Yoshihiro Kawaoka
Journal:  Nat Rev Microbiol       Date:  2005-08       Impact factor: 60.633

5.  Evolution of the H3 influenza virus hemagglutinin from human and nonhuman hosts.

Authors:  W J Bean; M Schell; J Katz; Y Kawaoka; C Naeve; O Gorman; R G Webster
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

6.  Influenza a viruses upregulate neutrophil toll-like receptor 2 expression and function.

Authors:  R M Lee; M R White; K L Hartshorn
Journal:  Scand J Immunol       Date:  2006-02       Impact factor: 3.487

7.  VEGF causes pulmonary hemorrhage, hemosiderosis, and air space enlargement in neonatal mice.

Authors:  T D Le Cras; R E Spitzmiller; K H Albertine; J M Greenberg; J A Whitsett; A L Akeson
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2004-03-19       Impact factor: 5.464

Review 8.  Evidence of an absence: the genetic origins of the 1918 pandemic influenza virus.

Authors:  Ann H Reid; Jeffery K Taubenberger; Thomas G Fanning
Journal:  Nat Rev Microbiol       Date:  2004-11       Impact factor: 60.633

9.  Systems-level comparison of host-responses elicited by avian H5N1 and seasonal H1N1 influenza viruses in primary human macrophages.

Authors:  Suki M Y Lee; Jennifer L Gardy; C Y Cheung; Timothy K W Cheung; Kenrie P Y Hui; Nancy Y Ip; Y Guan; Robert E W Hancock; J S Malik Peiris
Journal:  PLoS One       Date:  2009-12-14       Impact factor: 3.240

10.  Regulation of serum amyloid A3 (SAA3) in mouse colonic epithelium and adipose tissue by the intestinal microbiota.

Authors:  Christopher S Reigstad; Gunnel Ostergren Lundén; Jenny Felin; Fredrik Bäckhed
Journal:  PLoS One       Date:  2009-06-09       Impact factor: 3.240

View more
  14 in total

1.  Dynamic gene expression analysis in a H1N1 influenza virus mouse pneumonia model.

Authors:  Yanyan Bao; Yingjie Gao; Yujing Shi; Xiaolan Cui
Journal:  Virus Genes       Date:  2017-02-27       Impact factor: 2.332

2.  Sequencing, annotation, and characterization of the influenza ferret infectome.

Authors:  Alberto J León; David Banner; Luoling Xu; Longsi Ran; Zhiyu Peng; Kang Yi; Chao Chen; Fengping Xu; Jinrong Huang; Zhen Zhao; Zhen Lin; Stephen H S Huang; Yuan Fang; Alyson A Kelvin; Ted M Ross; Amber Farooqui; David J Kelvin
Journal:  J Virol       Date:  2012-12-12       Impact factor: 5.103

3.  Activation of the TREM-1 pathway in human monocytes by periodontal pathogens and oral commensal bacteria.

Authors:  M Varanat; E M Haase; J G Kay; F A Scannapieco
Journal:  Mol Oral Microbiol       Date:  2016-09-06       Impact factor: 3.563

4.  The Role of Extracellular Histones in Influenza Virus Pathogenesis.

Authors:  Harshini K Ashar; Nathan C Mueller; Jennifer M Rudd; Timothy A Snider; Mallika Achanta; Maram Prasanthi; Sivasami Pulavendran; Paul G Thomas; Akhilesh Ramachandran; Jerry R Malayer; Jerry W Ritchey; Rachakatla Rajasekhar; Vincent T K Chow; Charles T Esmon; Narasaraju Teluguakula
Journal:  Am J Pathol       Date:  2017-10-26       Impact factor: 4.307

5.  Influenza A/Hong Kong/156/1997(H5N1) virus NS1 gene mutations F103L and M106I both increase IFN antagonism, virulence and cytoplasmic localization but differ in binding to RIG-I and CPSF30.

Authors:  Samar K Dankar; Elena Miranda; Nicole E Forbes; Martin Pelchat; Ali Tavassoli; Mohammed Selman; Jihui Ping; Jianjun Jia; Earl G Brown
Journal:  Virol J       Date:  2013-07-25       Impact factor: 4.099

6.  Differential host response, rather than early viral replication efficiency, correlates with pathogenicity caused by influenza viruses.

Authors:  Peter S Askovich; Catherine J Sanders; Carrie M Rosenberger; Alan H Diercks; Pradyot Dash; Garnet Navarro; Peter Vogel; Peter C Doherty; Paul G Thomas; Alan Aderem
Journal:  PLoS One       Date:  2013-09-20       Impact factor: 3.240

7.  Neutrophils as Possible Therapeutic Targets in Severe Influenza Pneumonia.

Authors:  Teluguakula Narasaraju; Ashar Harshini
Journal:  J Infect Pulm Dis       Date:  2016-05-31

8.  Curcumin alleviates macrophage activation and lung inflammation induced by influenza virus infection through inhibiting the NF-κB signaling pathway.

Authors:  Yiming Xu; Ling Liu
Journal:  Influenza Other Respir Viruses       Date:  2017-07-11       Impact factor: 4.380

9.  Systems-based approach to examine the cytokine responses in primary mouse lung macrophages infected with low pathogenic avian Influenza virus circulating in South East Asia.

Authors:  Biruhalem Taye; Hui Chen; Myint Zu Myaing; Boon Huan Tan; Sebastian Maurer-Stroh; Richard J Sugrue
Journal:  BMC Genomics       Date:  2017-05-30       Impact factor: 3.969

10.  Kinetic characterization of PB1-F2-mediated immunopathology during highly pathogenic avian H5N1 influenza virus infection.

Authors:  Olivier Leymarie; Grégory Jouvion; Pierre-Louis Hervé; Christophe Chevalier; Valérie Lorin; Jérôme Lecardonnel; Bruno Da Costa; Bernard Delmas; Nicolas Escriou; Ronan Le Goffic
Journal:  PLoS One       Date:  2013-03-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.